VOLITIONRX

VOLITIONRX

VOLITIONRX

Volition's purpose is to develop blood-based tests to diagnose a wide range of cancers. We are not responsible for or endorse the content of any external links.
Founded
2010
Raised
$1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$1,000,000
Post-IPO equity - 2014
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when VOLITIONRX makes some noise.